NYSEAMERICAN:VTAK Catheter Precision (VTAK) Stock Price, News & Analysis $0.15 0.00 (0.00%) As of 10/9/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsInsider TradesNews and TrendsOwnershipSEC Filings About Catheter Precision Stock (NYSEAMERICAN:VTAK) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Catheter Precision alerts:Sign Up Key Stats Today's Range$0.15▼$1.5150-Day Range$0.15▼$2.1052-Week Range$0.13▼$3.20VolumeN/AAverage Volume1.54 million shsMarket Capitalization$2.17 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Catheter Precision, Inc. is a medical device company focused on developing technologies for cardiac electrophysiology, a field involving the diagnosis and treatment of heart-rhythm disorders. Its products are designed to support physicians during procedures used to evaluate and treat cardiac arrhythmias, including ventricular tachycardia and other irregular heart rhythms. The company’s product portfolio includes the VIVO system, a noninvasive 3D cardiac mapping and navigation platform intended to help clinicians identify the origin of ventricular arrhythmias and plan catheter-ablation procedures. Catheter Precision also markets LockeT, a device designed to help secure and manage catheters during electrophysiology procedures and support post-procedure access-site management. Catheter Precision was formerly known as Ra Medical Systems and adopted its current name as it shifted its focus toward cardiac electrophysiology technologies. The company serves hospitals, cardiac centers and electrophysiology specialists, primarily in the United States and selected international markets where its products have received applicable regulatory clearances or approvals.AI Generated. May Contain Errors. Read More Catheter Precision Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks15th Percentile Overall ScoreVTAK MarketRank™: 0.728181572545 of 5 starsCatheter Precision scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Catheter Precision. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Catheter Precision is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Catheter Precision is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCatheter Precision has a P/B Ratio of 0.04. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Catheter Precision's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.33% of the float of Catheter Precision has been sold short.Short Interest Ratio / Days to CoverCatheter Precision has a short interest ratio ("days to cover") of 0.09, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Catheter Precision has recently decreased by 20.78%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCatheter Precision does not currently pay a dividend.Dividend GrowthCatheter Precision does not have a long track record of dividend growth. News and Social Media0.0 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for Catheter Precision this week, compared to 2 articles on an average week. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Catheter Precision insiders have not sold or bought any company stock.Percentage Held by Insiders5.89% of the stock of Catheter Precision is held by insiders.Percentage Held by Institutions20.34% of the stock of Catheter Precision is held by institutions.Read more about Catheter Precision's insider trading history. Receive VTAK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Catheter Precision and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VTAK Stock News HeadlinesCatheter Precision (VTAK) Set to Announce Quarterly Earnings on ThursdayNovember 5 at 3:57 AM | americanbankingnews.comCatheter Precision Announces New FDA 510(k) Clearance for its VIVO System, Enabling Use in a Broader Patient PopulationNovember 2, 2026 | marketscreener.comMMy prediction for December 8thElon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout. | Behind the Markets (Ad)Flyte Aviation Rebrands and Executes Reverse Stock SplitOctober 5, 2026 | tipranks.comFlyte Aviation Launches Under NYSE American Ticker “VJET”October 5, 2026 | globenewswire.comCatheter Precision, Inc. will Change its Ticker to VJET from VTAKOctober 4, 2026 | marketscreener.comMCatheter Precision to rebrand as Flyte Aviation, adopt VJET tickerOctober 2, 2026 | msn.comCatheter Precision, Inc. Announces Board Approval of Name Change to Flyte Aviation, Inc., Ticker Symbol Change to VJET and 1-for-10 Reverse Stock SplitOctober 2, 2026 | quiverquant.comQSee More Headlines VTAK Stock Analysis - Frequently Asked Questions How have VTAK shares performed this year? Catheter Precision's stock was trading at $18.30 at the beginning of 2026. Since then, VTAK shares have decreased by 99.2% and is now trading at $0.1510. How were Catheter Precision's earnings last quarter? Catheter Precision, Inc. (NYSEAMERICAN:VTAK) released its quarterly earnings data on Monday, May, 18th. The company reported ($13.90) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($209.00) by $195.10. The business earned $432 thousand during the quarter, compared to the consensus estimate of $1.60 million. Catheter Precision had a negative net margin of 656.03% and a negative trailing twelve-month return on equity of 37.53%. When did Catheter Precision's stock split? Shares of Catheter Precision reverse split on Monday, August 18th 2025.The 1-19 reverse split was announced on Friday, August 15th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 15th 2025. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Company Calendar Last Earnings5/18/2026Today11/06/2026Next Earnings (Estimated)11/12/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSEAMERICAN:VTAK CIK1716621 Webwww.catheterprecision.com Phone973-691-2000FaxN/AEmployees14Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$17.18 million Net Margins-656.03% Pretax Margin-721.20% Return on Equity-37.53% Return on Assets-13.05% Debt Debt-to-Equity Ratio0.19 Current Ratio0.19 Quick Ratio0.18 Sales & Book Value Annual Sales$820 thousand Price / Sales2.65 Cash Flow$5.03 per share Price / Cash Flow0.03 Book Value$3.82 per share Price / Book0.04Miscellaneous Outstanding Shares14,390,000Free Float13,544,000Market Cap$2.17 million OptionableN/A Beta-0.99 The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NYSEAMERICAN:VTAK) was last updated on 10/9/2026 by MarketBeat.com Staff. From Our PartnersI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredTrump’s Secret Money ExposedIn 1974, a quiet deal between Henry Kissinger and the Saudis reshaped America's monetary order overnight, with...Porter & Company | SponsoredCritical SpaceX supplier w/ patented tech trading for $5President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon Musk about to bankrupt Amazon, Microsoft & Google?Jeff Brown, the former tech executive who called the rise of Bitcoin, Tesla, and Nvidia years early, is tracki...Brownstone Research | SponsoredOne stock to sell now that Libs have taken overA veteran analyst dubbed The Prophet by CNBC believes a major shift in Washington could create a rare opportun...Stansberry Research | Sponsored$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that l...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catheter Precision, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Catheter Precision With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VTAK Stock Alerts